Literature DB >> 32539546

The Association of Hypophosphatemia With Resistant Lactic Acidosis in Critical Care Illness.

Amr Essa1, Omar Kousa1, Dana Awad1, Makenzi Stevenson1, Bradley DeVrieze1, Douglas Moore1.   

Abstract

Critically ill patients are known to have a variety of electrolyte abnormalities. Lactic acidosis can frequently be seen secondary to shock states and is usually treated with aggressive volume resuscitation. Interestingly, hypophosphatemia is a potential cause of resistant lactic acidosis, which may not be as commonly identified or considered. We present a case of a 42-year-old man admitted twice over a span of 6 months with an elevated lactate level that did not resolve with volume resuscitation. It was ultimately determined that his lactic acidosis was due to hypophosphatemia after ruling out other potential causes. Phosphate replacement therapy resulted in the normalization of his lactate. In the literature, multiple theories have indicated the association of hypophosphatemia with lactic acidosis though no prior cases exist supporting a direct relationship. In this case, we set forth to evaluate the complicated relationship between all of these factors and to highlight the importance of early detection and treatment of hypophosphatemia, which may be beneficial in treating lactic acidosis.

Entities:  

Keywords:  case report; critical illness; hypophosphatemia; lactic acidosis; phosphorus

Mesh:

Substances:

Year:  2020        PMID: 32539546      PMCID: PMC7298210          DOI: 10.1177/2324709620934963

Source DB:  PubMed          Journal:  J Investig Med High Impact Case Rep        ISSN: 2324-7096


Introduction

Electrolyte disturbance is common in critical illness with various physiological pathways involved. Lactic acidosis and hypophosphatemia are among these disturbances, with the latter having an incidence of up to 34%. Importantly, they can have consequences affecting morbidity and mortality.[1,2] Understanding the underlying involved mechanism is essential for proper diagnosis and management, especially with regard to lactic acidosis, as it can present secondary to different mechanisms, and hypophosphatemia is underrecognized potential cause.

Case Presentation

A 42-year-old male with a history of chronic alcoholism and alcoholic liver cirrhosis presented to the emergency department with epigastric pain. He reported no smoking or illicit drug use. On presentation, he was afebrile with a blood pressure of 130/80 mmHg, heart rate of 122 beats per minute, respiratory rate of 18 breaths per minute, and oxygen saturation of 98% on room air. His physical examination was remarkable for scleral icterus, abdominal ascites, and epigastric tenderness. Initial laboratory evaluation was remarkable for lactic acidosis of 9.8 mmol/L, hypomagnesemia of 1.4, elevated B-hydroxybutyric acid of 53.9 mg/dL, low bicarbonate level of 8 mmol/L, and venous pH of 7.27, as shown in Table 1. Chest X-ray was unremarkable, and computed tomography scan of the abdomen showed findings of chronic pancreatitis. He was admitted to the intensive care unit for management of suspected starvation ketoacidosis and lactic acidosis, which was thought to be secondary to alcoholism/underlying liver cirrhosis. He was administered aggressive volume resuscitation and electrolyte replacement, as shown in Table 2. His markedly elevated lactate on admission of 9.8 mmol/L decreased to 5.1 mmol/L, yet a few hours later it increased to 9 mmol/L. During this same time period, his phosphate level dropped from 2.5 mg/dL to 1.1 mg/dL. At that point, phosphate replacement was initiated without further intravenous fluid and with the correction of phosphate levels, the lactate normalized, as shown in Figure 1. He was discharged home in stable condition on multivitamins, magnesium oxide, thiamine, and folic acid. Five months later, he presented to the emergency department with encephalopathy secondary to hypoglycemia with a glucose level of 26 mg/dL that was thought to be largely related to poor oral intake and vomiting before presentation, which was corrected by dextrose 50%. His vital signs were stable, and his initial laboratory work was remarkable for lactic acidosis of 21.1 mmol/L, elevated β-hydroxybutyric acid of 33.6 mg/dL, low bicarbonate level of <5 mmol/L, and venous pH of 6.96, as shown in Table 2. He was started on aggressive volume resuscitation and electrolyte replacement, as shown in Table 2. Notably, his lactate again initially improved from 21.1 mmol/L on admission to 14.5 mmol/L. However, his phosphate level over that same time period dropped from 6.5 mg/dL on admission to 1.1 mg/dL. Phosphate replacement was initiated without additional intravenous fluid resuscitation. With the correction of phosphate levels, his lactate normalized, as shown in Figure 2.
Table 1.

Laboratory Results on Presentation on the First Admission.

TestsLaboratory values
White blood cell (4000-12 000/µL)4.4
Hemoglobin (12-16 g/dL)12.6
Hematocrit (36% to 48%)37.4
Platelet (140 000-440 000/µL)34
Glucose (74-106 g/dL)50
Sodium (137-145 mmol/L)139
Potassium (3.5-5.1 mmol/L)3.7
Chloride (98-107 mmol/L)100
Carbon dioxide (22-30 mmol/L)8
Urea (9-20 mg/dL)5
Creatinine (0.7-1.2 g/dL)0.67
Total protein (6.3-8.2 g/dL)8.1
Albumin (3.5-5.0 g/dL)3.3
Calcium (8.4-10.2 mg/dL)8.6
Total bilirubin (0.2-1.3 mg/dL)3
Aspartate aminotransferase (15-46 IU/L)243
Alanine transaminase (4-50 IU/L)46
Alkaline phosphates (38-126 IU/L)308
Creatine kinase total (55-170 IU/L)27
Lipase (73-393 U/L)35
Brain natriuretic peptide (<124 pg/mL)144
Troponin (<0.04)<0.04
International normalized ratio (0.9-1.1)1.0
Magnesium (1.8-2.6 mg/dL)1.4
Phosphate (2.5-4.5 mg/dL)2.1
Lactate (0.5-1.0 mmol/L)9.8
β-Hydroxybutyric acid (0.2-2.8 mg/dL)53.9
Procalcitonin (<0.05 ng/mL)0.07
Ethanol level (<10 mg/dL)90
Venous pH (7.33-7.43)7.27
Table 2.

Laboratory Results on Presentation on the Second Admission.

TestsLaboratory values
White blood cell (4000-12 000/µL)11.6
Hemoglobin (12-16 g/dL)12.9
Hematocrit (36% to 48%)40.6
Platelet (140 000-440 000/µL)61
Glucose (74-106 g/dL)177
Sodium (137-145 mmol/L)145
Potassium (3.5-5.1 mmol/L)4.1
Chloride (98-107 mmol/L)103
Carbon dioxide (22-30 mmol/L)<5
Urea (9-20 mg/dL)15
Creatinine (0.7-1.2 g/dL)1.24
Total protein (6.3-8.2 g/dL)8.4
Albumin (3.5-5.0 g/dL)3.6
Calcium (8.4-10.2 mg/dL)8.5
Total bilirubin (0.2-1.3 mg/dL)1.5
Aspartate aminotransferase (15-46 IU/L)147
Alanine transaminase (4-50 IU/L)57
Alkaline phosphates (38-126 IU/L)189
Creatine kinase total (55-170 IU/L)131
Lipase (73-393 U/L)24
Brain natriuretic peptide (<124 pg/mL)166
Troponin (<0.04)<0.04
International normalized ratio (0.9-1.1)1.1
Magnesium (1.8-2.6 mg/dL)2.0
Phosphate (2.5-4.5 mg/dL)6.5
Lactate (0.5-1.0 mmol/L)21.1
β-Hydroxybutyric acid (0.2-2.8 mg/dL)33.6
Procalcitonin (<0.05 ng/mL)0.18
Ethanol level (<10 mg/dL)72
Venous pH (7.33-7.43)6.96
Figure 1.

Lactate and phosphate trending throughout the first admission (K, potassium; Phos, phosphate; D5%, dextrose 5%; LR, lactate Ringer’s; Na, sodium).

Figure 2.

Lactate and phosphate trending throughout the second admission (K, potassium; Phos, phosphate; D5%, dextrose 5%; LR, lactate Ringer’s; Na, sodium; HCO3, bicarbonate; D5W, dextrose 5% in water).

Laboratory Results on Presentation on the First Admission. Laboratory Results on Presentation on the Second Admission. Lactate and phosphate trending throughout the first admission (K, potassium; Phos, phosphate; D5%, dextrose 5%; LR, lactate Ringer’s; Na, sodium). Lactate and phosphate trending throughout the second admission (K, potassium; Phos, phosphate; D5%, dextrose 5%; LR, lactate Ringer’s; Na, sodium; HCO3, bicarbonate; D5W, dextrose 5% in water).

Discussion

Hypophosphatemia, defined as a serum phosphate less than 2.5 mg/dL, can be seen secondary to 3 general causes: decreased phosphate intake or intestinal absorption, increased renal excretion, or internal distribution of inorganic phosphate.[3] It is important to note that normal or even high phosphate levels can be present in total body phosphate depletion, and hypophosphatemia in the serum will not be evident until an intervention is initiated to induce the internal distribution of inorganic phosphate. Our patient’s phosphate level had been normal historically in the outpatient setting with a range between 4.0 and 4.3 mg/dL. However, during both hospitalizations, his phosphate levels on admission dropped precipitously within a few hours after volume resuscitation and administration of dextrose-containing fluid. It is thus crucial to monitor phosphate and other electrolytes carefully on several consecutive days, especially after initiation of nutrition or volume resuscitation to avoid such consequences that are referred to as refeeding syndrome, as shown in Tables 3 and 4. Also, our patient represents a good example of an important clinical entity of phosphate depletion in chronic alcoholism, which is largely related to poor phosphate intake and vitamin D intake, which in turn leads to decreased phosphate renal reabsorption and intestinal absorption.[4]
Table 3.

Electrolytes Trend Throughout the First Admission Along With Total Electrolytes Replacement Therapy Administered in a 24-Hour Period.

Hours since admission
024487296
Phosphate (2.5-4.9 mg/dL)2.11.12.92.54.2
Potassium (3.7-5.1 mmol/L)3.72.93.54.24.0
Magnesium (1.8-2.6 mg/dL)1.42.21.81.91.6
Electrolyte replacement3000 mg K-Phos3000 mg K-Phos80 mEq KCl1000 mg K-Phos1000 mg K-Phos
60 mEq KCl40 mmol K-Phos4 g Mag-sulfate2 g Mag-sulfate
2 g Mag-sulfate120 mEq KCl400 mg Mag-Ox
2 g Mag-sulfate

Abbreviations: K, potassium; Phos, phosphate; Mag, magnesium; Ox, oxide; Na sodium.

Table 4.

Electrolytes Trend Throughout the Second Admission Along With Total Electrolytes Replacement Therapy Administered in a 24-Hour Period.

Hours since admission
024487296
Phosphate (2.5-4.9 mg/dL)6.51.12.23.23.4
Potassium (3.7-5.1 mmol/L)5.14.83.13.43.7
Magnesium (1.8-2.6 mg/dL)2.01.82.01.81.5
Electrolyte replacement30 mmol K-Phos80 mEq KCl40 mEq KCl1000 mg K-Phos
5 g Mag-sulfate40 mmol K-Phos2 g Mag-Sulfate

Abbreviations: K, potassium; Phos, phosphate; Mag, magnesium; Ox, oxide; Na, sodium.

Electrolytes Trend Throughout the First Admission Along With Total Electrolytes Replacement Therapy Administered in a 24-Hour Period. Abbreviations: K, potassium; Phos, phosphate; Mag, magnesium; Ox, oxide; Na sodium. Electrolytes Trend Throughout the Second Admission Along With Total Electrolytes Replacement Therapy Administered in a 24-Hour Period. Abbreviations: K, potassium; Phos, phosphate; Mag, magnesium; Ox, oxide; Na, sodium. Internal distribution of inorganic phosphate is the most common cause of hypophosphatemia in critically ill patients and is of particular importance among alcoholics, such as our patient, who are admitted to the hospital and then experience a fall in their serum phosphate within a few hours.[5] This is largely related to intracellular transition of phosphate induced by insulin release as a response to dextrose-containing fluid administration, refeeding, or respiratory alkalosis that can occur with a hyperventilatory state in alcoholics.[6] Lactic acidosis may be seen in critically ill patients under many circumstances and is generally associated with poor clinical outcomes, particularly with sepsis and low-flow state.[2] The causes can be stratified according to whether tissue hypoxia is present or absent (Figure 3).[7] Also, it important to note the benign nature of elevated lactate that might happen with infusion of large volume of Ringer’s lactate. That increase in lactate is usually minimal, however, it can be significant in cases of decreased lactate clearance.[7,8] For example, decreased lactate clearance in liver dysfunction states, as the liver accounts for 70% of total body lactate clearance.[7]
Figure 3.

General scheme of causes of lactic acidosis.

General scheme of causes of lactic acidosis. Lactic acidosis should be viewed within the clinical context as the approach may differ depending on the etiology. Our patient had received a large volume of intravenous fluids despite the absence of clinical signs of shock or low-flow state. Given the persistence of his lactic acidosis despite this intervention, evaluation for other potential etiologies was sought. Although we suspected his underlying chronic alcoholism and cirrhosis were contributing, we also hypothesized that persistent lactic acidosis was related to hypophosphatemia. Various pathophysiological mechanisms exist to explain hypophosphatemia as a potential etiology, as outlined in Figure 4. Depletion of inorganic phosphate and adenosine triphosphate (ATP) with a fall in 2,3-diphosphoglycerate lead to decreased tissue oxygen delivery due to changes in hemoglobin, oxygen dissociation impairment, and consequently lactate production.[9,10] Furthermore, the phosphofructokinase enzyme in the liver, a central enzyme in the glycolysis process, will be stimulated by depletion in inorganic phosphate and ATP, promoting glycolysis and lactate formation. Additionally, alkalosis, which may develop with hypophosphatemia or secondary to hyperventilation in alcoholics, stimulate phosphofructokinase activity. Moreover, hepatic utilization of lactate into glucose will be impaired as it is an active process that requires 6 ATP molecules.[10,11] In our patient, his lactate clearance improved as demonstrated by normalization of lactate on correction of his hypophosphatemia and not related to volume resuscitation. This finding supports the relationship between improving lactic acidosis with correction of hypophosphatemia.
Figure 4.

Mechanisms of lactic acidosis in hypophosphatemia and chronic alcoholism.

Mechanisms of lactic acidosis in hypophosphatemia and chronic alcoholism.

Conclusion

The role of hypophosphatemia in resistant lactic acidosis has not been clearly established. We suggest future prospective studies to assess such a relation.
  10 in total

1.  Lactic acidosis.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  N Engl J Med       Date:  2015-03-12       Impact factor: 91.245

Review 2.  Disorders of phosphate metabolism.

Authors:  Jenny Leung; Martin Crook
Journal:  J Clin Pathol       Date:  2019-08-29       Impact factor: 3.411

Review 3.  Hypophosphatemia: an evidence-based approach to its clinical consequences and management.

Authors:  Jamshid Amanzadeh; Robert F Reilly
Journal:  Nat Clin Pract Nephrol       Date:  2006-03

Review 4.  The lactic acid response to alkalosis in panic disorder : an integrative review.

Authors:  R J Maddock
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

5.  Alterations of red-cell glycolytic intermediates and oxygen transport as a consequence of hypophosphatemia in patients receiving intravenous hyperalimentation.

Authors:  S F Travis; H J Sugerman; R L Ruberg; S J Dudrick; M Delivoria-Papadopoulos; L D Miller; F A Oski
Journal:  N Engl J Med       Date:  1971-09-30       Impact factor: 91.245

Review 6.  Refeeding syndrome and hypophosphatemia.

Authors:  Mark A Marinella
Journal:  J Intensive Care Med       Date:  2005 May-Jun       Impact factor: 3.510

Review 7.  Hypophosphatemia: an update on its etiology and treatment.

Authors:  André Gaasbeek; A Edo Meinders
Journal:  Am J Med       Date:  2005-10       Impact factor: 4.965

Review 8.  Treatment of hypophosphatemia in the intensive care unit: a review.

Authors:  Daniël A Geerse; Alexander J Bindels; Michael A Kuiper; Arnout N Roos; Peter E Spronk; Marcus J Schultz
Journal:  Crit Care       Date:  2010-08-03       Impact factor: 9.097

9.  Effect of intravenous lactated Ringer's solution infusion on the circulating lactate concentration: Part 3. Results of a prospective, randomized, double-blind, placebo-controlled trial.

Authors:  A Didwania; J Miller; D Kassel; E V Jackson; B Chernow
Journal:  Crit Care Med       Date:  1997-11       Impact factor: 7.598

10.  Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients.

Authors:  Kyle J Gunnerson; Melissa Saul; Shui He; John A Kellum
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

  10 in total
  1 in total

1.  Phosphate Dysregulation and Neurocognitive Sequelae.

Authors:  John Acquaviva; Hosam G Abdelhady; Mohammed S Razzaque
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.